News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,644 Results
Type
Article (1922)
Company Profile (2)
Press Release (70720)
Section
Business (21470)
Career Advice (9)
Deals (4552)
Drug Development (8186)
FDA (1816)
Job Trends (805)
News (37073)
Policy (3569)
Tag
Academia (96)
Accelerated approval (3)
Allergies (16)
Alliances (8166)
ALS (13)
Alzheimer's disease (165)
Antibody-drug conjugate (ADC) (78)
Approvals (1938)
Artificial intelligence (29)
Autoimmune disease (24)
Automation (1)
Bankruptcy (8)
Best Places to Work (591)
Biosimilars (71)
Biotechnology (5)
Bladder cancer (28)
Brain cancer (5)
Breast cancer (56)
Cancer (535)
Cardiovascular disease (20)
Career advice (9)
CAR-T (12)
CDC (1)
Cell therapy (51)
Cervical cancer (3)
Clinical research (7540)
Collaboration (285)
Compensation (19)
Complete response letters (6)
COVID-19 (194)
C-suite (72)
Cystic fibrosis (6)
Data (664)
Depression (14)
Dermatology (9)
Diabetes (32)
Diagnostics (631)
Digital health (5)
Drug discovery (36)
Drug pricing (1)
Duchenne muscular dystrophy (34)
Earnings (8063)
Events (7438)
Executive appointments (65)
FDA (2243)
Fibrodysplasia Ossificans Progressiva (1)
Funding (135)
Gene editing (6)
Generative AI (1)
Gene therapy (32)
GLP-1 (70)
Government (240)
Grass and pollen (1)
Guidances (39)
Healthcare (1086)
HIV (5)
Huntington's disease (2)
IgA nephropathy (19)
Immunology and inflammation (6)
Immuno-oncology (6)
Indications (15)
Infectious disease (214)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (34)
IPO (1639)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (1)
Layoffs (6)
Legal (953)
Liver cancer (19)
Longevity (2)
Lung cancer (99)
Lymphoma (39)
Manufacturing (101)
MASH (17)
Medical device (1166)
Medtech (1177)
Mergers & acquisitions (3086)
Metabolic disorders (89)
mRNA (4)
Multiple sclerosis (18)
NASH (1)
Neurodegenerative disease (30)
Neuropsychiatric disorders (6)
Neuroscience (293)
NextGen: Class of 2026 (219)
Non-profit (63)
Obesity (29)
Opinion (1)
Ovarian cancer (27)
Pain (18)
Pancreatic cancer (18)
Parkinson's disease (42)
Partnered (3)
Patents (59)
Patient recruitment (53)
Peanut (1)
People (5124)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (2031)
Phase 2 (3181)
Phase 3 (2843)
Pipeline (827)
Policy (2)
Postmarket research (251)
Preclinical (699)
Press Release (2)
Prostate cancer (22)
Radiopharmaceuticals (23)
Rare diseases (69)
Real estate (605)
Regulatory (2933)
Reports (6)
Research institute (97)
Rett syndrome (1)
RNA editing (2)
RSV (3)
Schizophrenia (18)
Series A (26)
Series B (22)
Service/supplier (1)
Sickle cell disease (7)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (423)
Stomach cancer (2)
Supply chain (12)
Vaccines (44)
Venture capital (6)
Weight loss (11)
Women's health (7)
Date
Last 7 days (63)
Last 30 days (238)
Last 365 days (2766)
2026 (761)
2025 (2704)
2024 (3265)
2023 (3822)
2022 (7017)
2021 (6377)
2020 (5872)
2019 (3871)
2018 (3014)
2017 (3571)
2016 (3180)
2015 (4043)
2014 (3038)
2013 (2601)
2012 (2776)
2011 (2904)
2010 (2663)
Location
Africa (88)
Alabama (4)
Arizona (12)
Asia (22072)
Australia (2464)
California (698)
Canada (402)
China (416)
Colorado (5)
Connecticut (22)
Delaware (6)
Europe (13208)
Florida (71)
Georgia (13)
Illinois (33)
India (43)
Indiana (41)
Japan (273)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (109)
Massachusetts (536)
Michigan (7)
Minnesota (34)
Missouri (3)
Nebraska (3)
Nevada (9)
New Hampshire (1)
New Jersey (412)
New York (254)
North Carolina (101)
Northern California (297)
Ohio (4)
Oregon (1)
Pennsylvania (127)
Rhode Island (1)
South America (109)
Southern California (333)
Tennessee (1)
Texas (56)
United States (2659)
Utah (26)
Virginia (52)
Washington D.C. (3)
Washington State (55)
Wisconsin (7)
72,644 Results for "neuraxis ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
March 26, 2026
·
3 min read
Press Releases
Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
March 5, 2026
·
3 min read
Press Releases
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
·
5 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results
March 12, 2026
·
18 min read
BioMidwest
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS) today announced the results of a multicenter registry study on IB-Stim for pediatric disorders of gut-brain interaction (DGBI). IB-Stim is NeurAxis’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology therapy.
March 27, 2024
·
5 min read
Press Releases
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
March 26, 2026
·
6 min read
Business
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the fourth quarter and fiscal year 2023 for the period ended December 31, 2023.
April 9, 2024
·
13 min read
Press Releases
Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd.
April 1, 2026
·
4 min read
Press Releases
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
February 18, 2026
·
5 min read
Business
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced the appointment of Timothy Henrichs as Chief Financial Officer (CFO), effective February 5, 2024.
January 31, 2024
·
4 min read
Previous
3 of 7,265
Next
